Los Institutos Nacionales de la Salud (NIH) están posponiendo el lanzamiento de su nuevo sitio web hasta el otoño para garantizar la mejor experiencia posible para todas las personas que utilizan nuestros sitios web para obtener información sobre la salud, investigación, oportunidades de financiamiento y otros recursos. Consulta las últimas actualizaciones y las preguntas frecuentes (disponibles en inglés).
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
During aging, loss of vision and cognition often coincide. In a new study, researchers funded by the National Eye Institute (NEI) and the National Institute on Aging (NIA) have found that vision loss precedes loss of mental capacity.
Vision researcher, T. Michael Redmond, Ph.D., chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, is a recipient of the 2018 António Champalimaud Vision Award for foundational science discoveries about the molecular
Scientists funded by the National Eye Institute (NEI) report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP).
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors.
Scientists have evidence that variants of the same gene that enables us to make connective tissue by crosslinking proteins is associated with unusual glaucoma.
National Eye Institute (NEI) Postdoctoral Fellow Aman George, Ph.D., has received a $65,000 grant from the Knights Templar Eye Foundation to identify new drug treatments for vision impairment in children with a type of albinism.